ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer-Reference-Cited by-同舟云学术

ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer

Published:2017-03-02 Issue:20 Volume:8 Page:32864-32872
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhou Jian-Kang¹,Zheng Yu-Zhu²³,Liu Xue-Sha¹,Gou Qiheng¹,Ma Rui¹,Guo Cheng-Lin¹,Croce Carlo M.⁴,Liu Lunxu¹,Peng Yong¹

Affiliation:

1. Department of Thoracic Surgery and Lab of Non-coding RNAs in Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, China

2. Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China

3. Department of Oncology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China

4. Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel humanized monoclonal antibodies against ROR1 for cancer therapy;Molecular Cancer;2024-08-13

2. Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies;Science China Life Sciences;2024-08-12

3. Variant Transcript of ROR1 ENST00000545203 Does Not Encode ROR1 Protein;Biomedicines;2024-07-16

4. Receptor tyrosine kinase-like orphan receptor 1: A novel antitumor target in gastrointestinal cancers;World Journal of Clinical Oncology;2024-05-24

5. A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer;Breast Cancer Research;2024-02-26